270 related articles for article (PubMed ID: 36157547)
1. Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.
Elvevi A; Elli EM; Lucà M; Scaravaglio M; Pagni F; Ceola S; Ratti L; Invernizzi P; Massironi S
World J Gastroenterol; 2022 Aug; 28(29):3767-3779. PubMed ID: 36157547
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal involvement and manifestations in systemic mastocytosis.
Sokol H; Georgin-Lavialle S; Grandpeix-Guyodo C; Canioni D; Barete S; Dubreuil P; Lortholary O; Beaugerie L; Hermine O
Inflamm Bowel Dis; 2010 Jul; 16(7):1247-53. PubMed ID: 20162539
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal manifestations of systemic mastocytosis.
Lee JK; Whittaker SJ; Enns RA; Zetler P
World J Gastroenterol; 2008 Dec; 14(45):7005-8. PubMed ID: 19058339
[TBL] [Abstract][Full Text] [Related]
4. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
Valent P; Akin C; Sperr WR; Horny HP; Arock M; Metcalfe DD; Galli SJ
Annu Rev Pathol; 2023 Jan; 18():361-386. PubMed ID: 36270293
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis demystified.
Veitch S; Radia DH
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):396-406. PubMed ID: 38066855
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
Nanagas VC; Kovalszki A
Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
Valent P
Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
12. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.
Gotlib J; Pardanani A; Akin C; Reiter A; George T; Hermine O; Kluin-Nelemans H; Hartmann K; Sperr WR; Brockow K; Schwartz LB; Orfao A; Deangelo DJ; Arock M; Sotlar K; Horny HP; Metcalfe DD; Escribano L; Verstovsek S; Tefferi A; Valent P
Blood; 2013 Mar; 121(13):2393-401. PubMed ID: 23325841
[TBL] [Abstract][Full Text] [Related]
13. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice.
Valent P; Hartmann K; Schwaab J; Alvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Sperr WR; Butterfield JH; Ustun C; Zanotti R; Radia DH; Castells M; Triggiani M; Schwartz LB; Orfao A; George TI; Sotlar K; Gotlib J; Reiter A; Horny HP; Arock M; Akin C; Metcalfe DD
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1999-2012.e6. PubMed ID: 35342031
[TBL] [Abstract][Full Text] [Related]
14. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).
Pardanani A
Blood; 2013 Apr; 121(16):3085-94. PubMed ID: 23426950
[TBL] [Abstract][Full Text] [Related]
15. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
16. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium.
Pyatilova P; Akin C; Alvarez-Twose I; Arock M; Bonadonna P; Brockow K; Butterfield JH; Broesby-Olsen S; Carter MC; Castells M; George TI; Gotlib J; Greiner G; Gülen T; Hartmann K; Hermine O; Horny HP; Jawhar M; Lange M; Lyons JJ; Maurer M; Metcalfe DD; Nedoszytko B; Niedoszytko M; Orfao A; Reiter A; Schwaab J; Sotlar K; Sperr WR; Triggiani M; Valent P; Siebenhaar F
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2015-2024. PubMed ID: 35724950
[TBL] [Abstract][Full Text] [Related]
17. Mastocytosis: a comprehensive insight.
VAN Gysel D; DE Maeseneer H; Oranje AP
G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
[TBL] [Abstract][Full Text] [Related]
18. Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and Therapy.
Niedoszytko M; Valent P; Nedoszytko B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068468
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Involvement in Mast Cell Activation Disorders.
Hsieh FH
Immunol Allergy Clin North Am; 2018 Aug; 38(3):429-441. PubMed ID: 30007461
[TBL] [Abstract][Full Text] [Related]
20. Mastocytosis.
Birn CS
Gastroenterol Nurs; 2018; 41(5):380-387. PubMed ID: 30272600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
